ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE

被引：473

作者：

DAS, KM ^{[1
]}

EASTWOOD, MA ^{[1
]}

MCMANUS, JPA ^{[1
]}

SIRCUS, W ^{[1
]}

机构：

[1] WESTERN GEN HOSP, WOLFSON GASTRO INTESTIN LABS, EDINBURGH, SCOTLAND

来源：

关键词：

D O I：

10.1056/NEJM197309062891001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：491 / 495

页数：5

共 31 条

[1] BARGEN J A, 1962, Am Surg, V28, P630
[2] BARON JH, 1962, LANCET, V1, P1094
[3] BOTTIGER L. E., 1963, GASTROENTEROLOGIA [BASEL], V100, P33
[4] ADVERSE REACTIONS TO SALICYLAZOSULFAPYRIDINE (AZULFIDINE) IN TREATMENT OF ULCERATIVE COLITIS
COLLINS, JR
[J]. SOUTHERN MEDICAL JOURNAL, 1968, 61 (04) : 354 - &
[5] DAS KM, 1972, GUT, V13, P840
[6] DEVADATTA S, 1960, Bull World Health Organ, V23, P587
[7] CONTROLLED TRIAL OF SULPHASALAZINE IN TREATMENT OF ULCERATIVE COLITIS
DICK, AP
PETRIE, A
GRAYSON, MJ
CARPENTER, RG
[J]. GUT, 1964, 5 (05) : 437 - &
[8] DYER NH, 1972, CLINICS GASTROENTERO, V1
[9] EVANS D A P, 1969, Journal of Medical Genetics, V6, P405, DOI 10.1136/jmg.6.4.405
[10] EVANS DAP, 1965, CLIN PHARMACOL THER, V6, P430